AXGN: Q2 2025 Results Furnished; Presentation Posted (Aug 5, 2025)

Axogen, Inc. (AXGN) filed an 8-K on August 5, 2025.

Rhea-AI Filing Summary

Axogen, Inc. (AXGN) filed an 8-K on August 5, 2025.

The filing furnishes a press release announcing second quarter 2025 financial results (Exhibit 99.1) and a second quarter 2025 financial results presentation posted to the company website and furnished as Exhibit 99.2. The company explicitly states these items are furnished, not filed, and therefore not subject to Section 18 liability or incorporated by reference unless expressly stated in a future filing.

The report is signed by Marc Began, Executive Vice President, General Counsel and Chief Compliance Officer.

Insights

Financial Analyst

TL;DR: Routine earnings 8-K furnishing; the filing provides access to Q2 materials but contains no financial metrics itself.

Axogen furnished its Q2 2025 earnings press release (Exhibit 99.1) and a financial results presentation (Exhibit 99.2) and posted the presentation to its investor website. The 8-K frames these items as furnished, not filed, limiting Section 18 liability. Because the filing text does not include income statement or balance sheet figures, investors must review the referenced exhibits for quantitative performance, trends, or guidance.

Corporate Governance Expert

TL;DR: Standard disclosure practice; company clarifies furnished vs filed status and documents timely dissemination.

The 8-K follows common governance practice by furnishing a press release and presentation and explicitly stating they are not "filed" for Section 18 purposes. The filing documents the dissemination of material investor communications and identifies the authorized signatory. No governance actions, officer or director changes, material contracts, or litigation matters are reported in this filing.

8-K Event Classification

3 items: 2.02, 7.01, 9.01

3 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AXGN report on August 5, 2025?

Axogen furnished a press release announcing its second quarter 2025 financial results, filed as Exhibit 99.1 of the 8-K.

Did Axogen provide an investor presentation for Q2 2025?

Yes. Axogen posted a second quarter 2025 financial results presentation to its investor website and furnished it as Exhibit 99.2.

Are the press release and presentation "filed" with the SEC?

No. The 8-K states the press release and presentation are furnished, not filed, and thus are not subject to Section 18 liability or automatically incorporated by reference.

Which exhibits are included with the 8-K?

Exhibit 99.1 is the earnings press release, Exhibit 99.2 is the Q2 financial results presentation, and Exhibit 104 is the cover page interactive data file.

Who signed the 8-K for Axogen?

The report is signed by Marc Began, Executive Vice President, General Counsel and Chief Compliance Officer, dated August 5, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/05/2025 - 07:02 AM Learn about SEC filing dates

0000805928false00008059282025-08-052025-08-05

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 5, 2025

AXOGEN, INC.

(Exact Name of Registrant as Specified in Charter)

Minnesota

(State or Other Jurisdiction of

Incorporation or Organization)

001-36046

(Commission File Number)

41-1301878

(I.R.S. Employer Identification No.)

13631 Progress Boulevard, Suite 400 Alachua, Florida

(Address of principal executive offices)

32615

(Zip Code)

(386) 462-6800

(Registrant's telephone number, including area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of exchange on which registered
Common Stock, $0.01 par value			AXGN			The Nasdaq Stock Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02 Results of Operations and Financial Condition

On August 5, 2025, Axogen, Inc. (the “Company”) issued a press release announcing its second quarter 2025 financial results. A copy of the press release is furnished as Exhibit 99.1.

The information furnished pursuant to Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1 hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of such section, nor shall it be incorporated by reference into future filings by the Company under the Securities Act of 1933, as amended (the “Securities Act”), or under the Exchange Act, unless the Company expressly sets forth in such future filing that such information is to be considered “filed” or incorporated by reference therein.

Item 7.01 Regulation FD Disclosure

On August 5, 2025, the Company posted a second quarter 2025 financial results presentation to its website at https://ir.axogeninc.com/news-events. The Company may use the financial results presentation from time to time in conversation with analysts, investors, and others. A copy of the presentation is furnished as Exhibit 99.2.

The information in this Item 7.01, including Exhibit 99.2, is being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference into any filing under the Securities Act or Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits

(d) Exhibits

Exhibit No.			Description
99.1			Axogen Inc. Earnings Press Release, dated August 5, 2025
99.2			Axogen Inc. Second Quarter Financial Results Presentation, dated August 5, 2025
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			AXOGEN, INC.
Dated: August 5, 2025			By:			/s/ Marc Began
						Marc Began
						Executive Vice President, General Counsel and Chief Compliance Officer